Other

Cyclophosphamide, old dogs with new tricks?

Key opinions leaders in the field of haematopoetic stem cell transplantation (HSCT) will address the role of Cyclophosphamide, an anti-cancer chemotherapy drug, during the 42nd Annual Meeting of the European Society for Blood ...

Oncology & Cancer

Genetic variant ups risk of graft-versus-host disease in HSCT

(HealthDay)—The risk of acute graft-versus-host disease (GVHD) in hematopoietic stem cell transplantation with HLA-DPB1 mismatching is influenced by the HLA-DPB1 rs9277534 expression marker, according to a study published ...

page 5 from 7